Osman Vırıt

843 total citations
36 papers, 677 citations indexed

About

Osman Vırıt is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Osman Vırıt has authored 36 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Psychiatry and Mental health, 9 papers in Clinical Psychology and 6 papers in Pharmacology. Recurrent topics in Osman Vırıt's work include Bipolar Disorder and Treatment (13 papers), Electroconvulsive Therapy Studies (8 papers) and Schizophrenia research and treatment (8 papers). Osman Vırıt is often cited by papers focused on Bipolar Disorder and Treatment (13 papers), Electroconvulsive Therapy Studies (8 papers) and Schizophrenia research and treatment (8 papers). Osman Vırıt collaborates with scholars based in Türkiye, United Kingdom and United States. Osman Vırıt's co-authors include Haluk A. Savaş, Hasan Herken, Efkan Uz, Hüseyın Özyurt, Ömer Akyol, Sadık Söğüt, Abdurrahman Altındağ, Alican Dalkiliç, Ahmet Ünal and Mahmut Bulut and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular Psychiatry and Psychiatry Research.

In The Last Decade

Osman Vırıt

31 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Osman Vırıt Türkiye 12 288 266 136 94 85 36 677
Murat Eren Özen Türkiye 11 298 1.0× 204 0.8× 165 1.2× 89 0.9× 57 0.7× 36 710
Salih Saygın Eker Türkiye 11 336 1.2× 137 0.5× 240 1.8× 103 1.1× 55 0.6× 25 744
Mariana Pedrini Brazil 16 334 1.2× 336 1.3× 94 0.7× 180 1.9× 68 0.8× 29 783
Hitoshi Maeshima Japan 20 262 0.9× 240 0.9× 109 0.8× 148 1.6× 60 0.7× 35 806
Aslı Sarandöl Türkiye 14 404 1.4× 210 0.8× 279 2.1× 157 1.7× 57 0.7× 52 989
Keila M. Ceresér Brazil 11 324 1.1× 243 0.9× 161 1.2× 117 1.2× 35 0.4× 16 665
Michael Maes Thailand 14 390 1.4× 231 0.9× 152 1.1× 118 1.3× 89 1.0× 37 675
Kristy Kohlmann Australia 11 447 1.6× 404 1.5× 101 0.7× 58 0.6× 41 0.5× 14 709
Russell E. Scheffer United States 16 352 1.2× 575 2.2× 152 1.1× 154 1.6× 177 2.1× 32 1.1k
Susan Jeavons Australia 8 370 1.3× 306 1.2× 92 0.7× 55 0.6× 31 0.4× 10 573

Countries citing papers authored by Osman Vırıt

Since Specialization
Citations

This map shows the geographic impact of Osman Vırıt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osman Vırıt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osman Vırıt more than expected).

Fields of papers citing papers by Osman Vırıt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osman Vırıt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osman Vırıt. The network helps show where Osman Vırıt may publish in the future.

Co-authorship network of co-authors of Osman Vırıt

This figure shows the co-authorship network connecting the top 25 collaborators of Osman Vırıt. A scholar is included among the top collaborators of Osman Vırıt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osman Vırıt. Osman Vırıt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kokaçya, Mehmet Hanifi, et al.. (2016). Symptomatic Remission Determines Functional Improvement and Quality of Life in Schizophrenia. Nöro Psikiyatri Arşivi. 53(4). 328–333. 6 indexed citations
2.
Bülbül, Feridun, Osman Vırıt, Gökay Alpak, et al.. (2013). Are oxidative stress markers useful to distinguish schizoaffective disorder from schizophrenia and bipolar disorder?. Acta Neuropsychiatrica. 26(2). 120–124. 19 indexed citations
3.
Ünal, Ahmet, et al.. (2013). Effective Treatment of Catatonia by Combination of Benzodiazepine and Electroconvulsive Therapy. Journal of Ect. 29(3). 206–209. 25 indexed citations
4.
Vırıt, Osman, Alican Dalkiliç, Mahmut Bulut, et al.. (2010). Depresyonda EKT Sonrası Süperoksit Dismutaz Aktivitesi Düşüyor ve EKT'ye Kötü Yanıtla Korelasyon Gösteriyor. Nöro Psikiyatri Arşivi. 48(3). 1–1. 4 indexed citations
5.
Altındağ, Özlem, Abdurrahman Altındağ, Osman Vırıt, et al.. (2009). Bone mineral density in schizophrenia patients on antipsychotics. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 19(4). 402–406. 6 indexed citations
6.
Vırıt, Osman, Abdurrahman Altındağ, Feridun Bülbül, Haluk A. Savaş, & Alican Dalkiliç. (2009). Long-acting typical and atypical antipsychotics in treatment of schizophrenia: A retrospective comparison. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 19(2). 119–127. 3 indexed citations
7.
Vırıt, Osman, Abdurrahman Altındağ, Mehmet Yumru, et al.. (2009). A Defect in the Antioxidant Defense System in Schizophrenia. Neuropsychobiology. 60(2). 87–93. 55 indexed citations
8.
Vırıt, Osman, et al.. (2009). Improvement of restless legs syndrome and trichotillomania with aripiprazole. Journal of Clinical Pharmacy and Therapeutics. 34(6). 723–725. 8 indexed citations
9.
Bulut, Mahmut, Haluk A. Savaş, Abdurrahman Altındağ, Osman Vırıt, & Alican Dalkiliç. (2009). Beneficial effects ofN-acetylcysteine in treatment resistant schizophrenia. The World Journal of Biological Psychiatry. 10(4-2). 626–628. 60 indexed citations
10.
Vırıt, Osman, Abdurrahman Altındağ, Şahabettin Selek, et al.. (2008). Increased Plasma Ceruloplasmin Levels in Schizophrenia. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 18(4). 282–287. 7 indexed citations
11.
Vırıt, Osman, et al.. (2008). Gebelikte sosyodemografik değişkenlerin kaygı ve depresyon düzeyleriyle ilişkisi. 45(3). 85–91. 2 indexed citations
12.
Vırıt, Osman, Salih Selek, Mahmut Bulut, et al.. (2008). High ceruloplasmin levels are associated with obsessive compulsive disorder: a case control study. Behavioral and Brain Functions. 4(1). 52–52. 17 indexed citations
13.
Yumru, Mehmet, Haluk A. Savaş, Mehmet Hanifi Kokaçya, & Osman Vırıt. (2007). Long acting risperidone in treatment of schizophrenia:A retrospective study. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 17(3). 119–123. 4 indexed citations
14.
Vırıt, Osman, et al.. (2007). Patients' and Their Relatives' Attitudes Toward Electroconvulsive Therapy in Bipolar Disorder. Journal of Ect. 23(4). 255–259. 35 indexed citations
15.
Yumru, Mehmet, Fatma Sırmatel, Osman Vırıt, et al.. (2006). Anxiety and depression levels in interferon using and non using hepatitis C patients. SHILAP Revista de lepidopterología. 16(3). 155–159. 1 indexed citations
16.
Selek, Salih, Hasan Herken, Hamdi Tutkun, et al.. (2006). Massive uvula oedema during lithium therapy and resolution after lithium discontinuation. International Journal of Psychiatry in Clinical Practice. 10(1). 73–74.
17.
Herken, Hasan, et al.. (2004). Alexithymic features in migraine patients. European Archives of Psychiatry and Clinical Neuroscience. 254(3). 182–6. 41 indexed citations
18.
Herken, Hasan, et al.. (2003). The Relationship Between the Response to Risperidone Treatment and 5-HT2A Receptor Gene (T102C and 1438G/A) Polymorphism in Schizophrenia. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 13(4). 161–166. 13 indexed citations
19.
Herken, Hasan, et al.. (2001). Psikiyatri hastalarında sitokrom P450 2D6 yavaş ve ultra hızlı metabolizör sıklıkları. Turkish Journal of Psychiatry. 12(2). 83–88. 1 indexed citations
20.
Herken, Hasan, Efkan Uz, Hüseyın Özyurt, et al.. (2000). Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Molecular Psychiatry. 6(1). 66–73. 215 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Murat Eren Özen Breakdown of academic impact, for papers by Salih Saygın Eker Breakdown of academic impact, for papers by Mariana Pedrini Breakdown of academic impact, for papers by Hitoshi Maeshima Breakdown of academic impact, for papers by Aslı Sarandöl Breakdown of academic impact, for papers by Keila M. Ceresér Breakdown of academic impact, for papers by Michael Maes Breakdown of academic impact, for papers by Kristy Kohlmann Breakdown of academic impact, for papers by Russell E. Scheffer Breakdown of academic impact, for papers by Susan Jeavons
Rankless by CCL
2026